Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Dyslipidemia - Epidemiology Forecast to 2032
... Austria. Dyslipidemia: Disease Understanding Dyslipidemia Overview Dyslipidemias (defined as raised plasma concentrations of total cholesterol, LDL cholesterol or triglycerides, or a low plasma concentration of HDL cholesterol or a combination of these features) are major ... Read More
-
Vietnam Pharmaceuticals Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2017-2027
... E-Pharmacy), By Region, Competition Forecast & Opportunities, 2017-2027 Vietnam pharmaceuticals market is anticipated to grow at a formidable rate during the forecast period. The market growth can be attributed to the rising development of medicinal ... Read More
-
North America Outbound Medical Tourism Services Market, By Therapeutic Application (Cosmetic Surgery Treatment, Dental Treatment, Cardiovascular Treatment, Orthopedic Treatment, Cancer Treatment, Fertility Treatment, Weight Loss Treatment, Spinal Surgery
... By Countries (U.S., Canada) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Outbound medical tourism is defined as traveling of patients outside their country to avail various medical treatments. The preferred countries by ... Read More
-
Global Anastomosis Devices Market Size, Share & Industry Trends Analysis Report By Product Type, By Application (Cardiovascular Surgery, Gastrointestinal Surgery), By End User, By Regional Outlook and Forecast, 2022 - 2028
... Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 5.5% CAGR during the forecast period. A connection between cavities or passages that ordinarily branch or diverge, such as ... Read More
-
Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share & Trends Analysis Report By Modality (Computed Tomography, Nuclear Medicine), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2022 - 2030
... to 2030, according to a new report by Grand View Research, Inc. Increase in coronary diseases and deaths associated with it calls for better and early diagnosis of the condition. Precise scan interpretation and technologically ... Read More
-
North America Anastomosis Devices Market Size, Share & Industry Trends Analysis Report By Product Type, By Application (Cardiovascular Surgery, Gastrointestinal Surgery), By End User, By Country and Growth Forecast, 2022 - 2028
... Anastomosis Devices Market would witness market growth of 4.1% CAGR during the forecast period (2022-2028). Technological advancements in various medical device companies would aid in the improvement of the functionality and endurance of anastomosis devices. ... Read More
-
Dyslipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Dyslipidemia (Metabolic Disorders) pipeline landscape. Dyslipidemia is defined as elevation of the total cholesterol, the bad low-density lipoprotein (LDL) cholesterol and the triglyceride concentrations, and a decrease in the good high-density lipoprotein ... Read More
-
Europe Anastomosis Devices Market Size, Share & Industry Trends Analysis Report By Product Type, By Application (Cardiovascular Surgery, Gastrointestinal Surgery), By End User, By Country and Growth Forecast, 2022 - 2028
... Market would witness market growth of 4.7% CAGR during the forecast period (2022-2028). Anastomosis devices are often utilized in coronary artery bypass surgery to enhance the left ventricular system's operational efficiency and boost the patient's ... Read More
-
Clinical Trials Site Management Organizations Market Size, Share & Trends Analysis Report By Clinical Trail Services/Components, By Phase, By Therapeutic Areas (Oncology, Cardiology, CNS), By Region, And Segment Forecasts, 2022 - 2030
... Research, Inc. The market is expected to expand at a CAGR of 6.1% from 2022 to 2030. Site management organizations (SMOs) are essential elements of pharmaceutical and biopharmaceutical companies. Such organizations help to limit the ... Read More
-
Global Heart Health Functional Food Market Size study, by Type (Breakfast Cereals, Dairy Products, Edible Oils, Nutritional Bars, Others (Eggs & Wine)), by Distribution Channel (Hypermarkets, Supermarkets, Departmental Stores, Grocery/ Retailers) and Regional Forecasts 2022-2028
... Global Heart Health Functional Food Market is valued at approximately USD 447.17 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.8 % over the forecast period 2022-2028. ... Read More
-
Minimally Invasive Surgical Instruments Market Size, Share & Trends Analysis Report By Device (Handheld Instruments, Inflation Devices), By Application (Cardiac, Gastrointestinal), By End Use, And Segment Forecasts, 2022 - 2030
... Growth & Trends The global minimally invasive surgical instruments market size is estimated to reach USD 60.65 billion by 2030 registering a CAGR of 9.8% from 2022 to 2030 according to a new report by ... Read More
-
North America Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
... (Patients, Providers, Payers, and Employers) The North America digital therapeutics market is expected to reach US$ 7,323.29 million by 2028 from US$ 1,740.46 million in 2021; it is estimated to grow at a CAGR of ... Read More
-
The US Cardiovascular Needle Market: Analysis By Type, By Application, By Usage, By End User, Size and Trends with Impact of COVID-19 and Forecast up to 2026
... US$21.94 million in 2021, and is foreseen to reach US$31.53 million by 2026. A surgical suture, often known as a stitch or stitches, is a medical device that is used to hold tissues together and ... Read More
-
Europe Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
... Providers, Payers, and Employers) The Europe digital therapeutics market is expected to reach US$ 1,338.13 million by 2028 from US$ 1,023.59 million in 2021; it is estimated to grow at a CAGR of 22.9% from ... Read More
-
Asia Pacific Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
... (Patients, Providers, Payers, and Employers) The Asia Pacific digital therapeutics market is expected to reach US$ 3,470.31 million by 2028 from US$ 767.23 million in 2021; it is estimated to grow at a CAGR of ... Read More
-
Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update"" provides an overview of Diastolic Heart Failure Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Congestive Heart Failure (CHF) Treatment Devices Market By Product Type (Pacemakers, Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillators, Ventricular Assist Devices): Global Opportunity Analysis and Industry Forecast, 2020-2030
... valued at $11,897.97 million 2020, and is estimated to reach $20,470.14 million by 2030, growing at a CAGR of 5.6% from 2021 to 2030.Congestive heart failure (CHF) is a physiological condition that has an adverse ... Read More
-
Vegan Foods Market: Current Analysis and Forecast (2021-2027)
... Cardiovascular Disease, and type 2 Diabetes is driving the growth of the plant-based protein market. In a survey by the American Journal of Lifestyle Medicine, the majority (83%) agreed that a plant-based diet is a ... Read More
-
Global Senolytic Drugs Market, By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others), By Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast and Opportunities, 2017-2027
... Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast and Opportunities, 2017-2027 The global senolytic drugs market is expected to grow at a significant rate during the forecast period. The market growth can be attributed ... Read More
-
Global Clot Buster Drugs Market, By Type (Fibrin Specific Drugs {Tissue Plasminogen Activator, Reteplase, Tenecteplase, Others} v/s Non-Fibrin Specific Drugs {Urokinase, Streptokinase, Plasminogen Activating Complex}), By Application (Myocardial Infarction, Pulmonary Embolism, Deep Vein Thrombosis, Acute Ischemic Strokes, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast and Opportunities, 2017-2027
... Ischemic Strokes, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast and Opportunities, 2017-2027 The global clot buster drugs market is anticipated to register growth at a formidable rate during ... Read More
-
Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Atrial Fibrillation (Cardiovascular) pipeline landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor ... Read More
-
Novel Cardiovascular Drug Delivery Devices Market, 2022-2035
... WHO, around one third of the annual global deaths (an estimated 18 million) can be attributed to cardiac disorders. Specifically, coronary artery disease (CAD) is the most common form of cardiovascular disorder; around 11 million ... Read More
-
Myocarditis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Myocarditis (Cardiovascular) pipeline landscape. Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by ... Read More
-
Myocardial Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Myocardial Ischemia (Cardiovascular) pipeline landscape. Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, ... Read More
-
Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Congestive Heart Failure (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure ... Read More
Research Assistance
